Is Apogee stock a buy? Terrific results and great guidance -- so why isn't Apogee holding on to its gains? Does anything in this news make Apogee stock less of a buy than it seems?

Apogee Enterprises beat on top and bottom lines this morning. Management also guided investors to expect strong profits this year. But Apogee didn't actually earn any profit in Q1, and it burned ...

Apogee raises FY26 sales and EPS outlook amid tariff mitigation and segment momentum Jun. 27, 2025 2:14 PM ET Apogee Enterprises, Inc. (APOG) Stock AI-Generated Earnings Calls Insights Play (9min) ...

The science behind why the Earth will spin just a little bit faster on July 9, July 22, and August 5, this year.

Apogee Enterprises, Inc. (NASDAQ:APOG) is one of the 12 Small Cap Stocks with High Upside Potential. On June 26, Apogee Enterprises Board of Directors declared a quarterly cash dividend of $0.26 ...

(RTTNews) - Apogee Enterprises Inc. (APOG), a provider of architectural building products and services, on Friday recorded a net loss for the first quarter, reflecting higher expenses amidst ...

MINNEAPOLIS - Apogee Enterprises, Inc. (NASDAQ: APOG) reported better-than-expected first quarter results and raised its full-year guidance on Friday. The architectural products maker saw its ...

Investing.com -- Apogee (NASDAQ: APOG) Therapeutics, Inc. (NASDAQ: APGE) stock surged 24% on Monday after the clinical-stage biotechnology company announced positive 16-week data from its Phase 2 ...

Be a sport and try real fishing with eggs or cut herring under a bobber along with Vibrax spinners. Look for jumpers along ...

Apogee Enterprises (NASDAQ: APOG) stock, a specialist in architectural glass and metals, surged as much as 26% in early trading Friday before giving back most its gains and retreating to a 6% ...

Fight your way through the Rising Heat, a gladiator style space spectacle bankrolled by the Extraterrestrial Elite! Take flight with a diverse cast of pilots, ships and weapons! Choose upgrades, ...

Flow Cytometry's growth accelerates as immuno-oncology and liquid biopsy markets expand, driving cancer research investment. Explore advancements in single-cell genomics and biotech opportunities in ...